as 05-08-2025 4:00pm EST
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
Founded: | 1989 | Country: | United States |
Employees: | N/A | City: | IRVINE |
Market Cap: | 8.2B | IPO Year: | 2007 |
Target Price: | $187.00 | AVG Volume (30 days): | 591.1K |
Analyst Decision: | Buy | Number of Analysts: | 6 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -9.23 | EPS Growth: | N/A |
52 Week Low/High: | $101.61 - $194.88 | Next Earning Date: | 05-06-2025 |
Revenue: | $2,126,800,000 | Revenue Growth: | 16.68% |
Revenue Growth (this year): | -26.14% | Revenue Growth (next year): | 7.82% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
REYNOLDS CRAIG B | MASI | Director | Mar 14 '25 | Sell | $166.13 | 2,053 | $341,067.97 | 16,581 | |
Muhsin Bilal | MASI | Chief Operating Officer | Mar 10 '25 | Sell | $167.65 | 30,000 | $5,024,585.10 | 51,772 |
MASI Breaking Stock News: Dive into MASI Ticker-Specific Updates for Smart Investing
Simply Wall St.
16 hours ago
Zacks
2 days ago
MedTech Dive
2 days ago
Business Wire
2 days ago
Thomson Reuters StreetEvents
2 days ago
Cybersecurity Dive
2 days ago
Verdict
2 days ago
GuruFocus.com
2 days ago
The information presented on this page, "MASI Masimo Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.